Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 89

Adding zinc to Botox for cervical dystonia

Official title: Evaluation of Supplemental Zinc as an Adjunct to Prolong the Duration of Benefit After Botulinum Toxin Injections in Subjects With Cervical Dystonia

Run by University of Florida · NCT07140874 · Data updated 2026-11-12

This will test whether taking daily zinc citrate after a Botox injection helps people with cervical dystonia keep symptom relief longer.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment25 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedJune 1, 2026
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedMay 15, 2026
Trial IDNCT07140874 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with diagnosed cervical dystonia who have been receiving regular Botox injections for at least one year and have a good response to treatment are ideal candidates.

Probably not a fit

Patients who do not respond to Botox, have a zinc allergy, are pregnant or breastfeeding, or already take high-dose zinc that would exceed safe limits are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind, placebo-controlled crossover trial will enroll about 20 adults with cervical dystonia who already receive regular botulinum toxin type A injections at the University of Florida Movement Disorders Clinic. Participants will take zinc citrate 30 mg daily or matching placebo for three months after a scheduled Botox injection, then switch to the other treatment for another three months while keeping the same injection pattern. Outcomes include duration of symptom relief after injections, safety and tolerability measured by serum zinc, vitamin B12 and CBC, and patient-reported quality of life and functional measures. Clinic visits and blood draws occur every three months to coincide with routine Botox injections.

Why it matters

Potential benefit: If successful, patients might get longer-lasting relief from Botox and potentially need injections less often.

How similar studies have gone: Using zinc specifically to extend the benefit of botulinum toxin is largely novel and there is limited prior clinical evidence for this exact approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-89 years.
* Diagnosed with cervical dystonia.
* Receiving regular BoNT type A (Botox) injections for at least six months.

Exclusion Criteria:

* Known allergy or intolerance to zinc.
* Significant comorbidities or concurrent medications that could interfere with study outcomes.
* Pregnant or breastfeeding women.
* Already taking a zinc supplement which would exceed tolerable upper intake level in adults (40 mg elemental zinc per day) with addition of zinc study supplement.

Where it's running

  • Norman Fixel Institute for Neurological Diseases
    Gainesville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.